Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Prevenar 13 Patent Challenge Closely Watched As Test Case

Executive Summary

Ruling could come as early as next month in international humanitarian group MSF’s challenge to Pfizer's application for Indian patent on its blockbuster pneumococcal vaccine; observers see ruling as test of whether India is sticking to its stringent patent policy in face of growing pressure from foreign pharmaceutical companies.

Advertisement

Related Content

Interview: GSK India's Playbook For Vaccines Dominance

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS118951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel